Treated with Capzimin, the viability and motility of ESCC cells were obviously inhibited (Figure S10B and S10C), and the protein expression of SNAIL was reduced in both KYSE 30 and KYSE 150 cells (Figure S10D). This evidence concerns the gene SNAI1 and esophageal squamous cell carcinoma.